LimmaTech Biologics

About:

LimmaTech Biologics AG is a clinical stage biopharmaceutical company.

Website: https://lmtbio.com/

Top Investors: AXA Investment Managers, Tenmile, Adjuvant Capital, Repair Impact Fund

Description:

LimmaTech Biologics AG is a clinical-stage biopharmaceutical company.

Total Funding Amount:

$39.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Schlieren, Zurich, Switzerland

Founded Date:

2015-01-01

Contact Email:

info(AT)lmtbio.com

Founders:

Michael Kowarik, Paul Wolfrom, Veronica Gambillara Fonck

Number of Employees:

11-50

Last Funding Date:

2024-02-01

IPO Status:

Private

Industries: